Nuclear Imaging in Women and Special Populations


Nuclear Imaging in Women and Special Populations: From Diagnosis to Treatment and Beyond

The half-day virtual meeting focused on cardiovascular disease (CVD) in women as well as underrepresented populations, including liver, renal, and heart transplant patients.  

Renowned experts examined which types of CVD are more prevalent in women, traditional and non-traditional risk factors, and atypical symptoms and clinical presentations, which can present challenges in proper diagnosis.

'Nuclear Imaging in Women and Special Populations' discussed sex-specific differences, which impact recognition and proper diagnosis along with the latest evidence and clinical recommendations for managing female patients with CVD.


Participants may earn up to 4* AMA PRA Category 1 Credits™ and ABIM MOC points.

Learn why this is a one-of-a-kind meeting!


Program Overview 

Chaired by Renée Bullock-Palmer, MD, FASNC, and Rupa Sanghani, MD, FASNC, this program featured a distinguished panel of cardiologists specializing in the diagnosis and treatment of CVD, which continues to be the leading cause of death in women.

This comprehensive course discussed the topic of disparities in care in underrepresented populations, particularly related to maternal morbidity and the role of nuclear imaging in the assessment of ischemia and microvascular disease as well as liver, renal, and heart transplant patients.

Participants of this course will expand their knowledge of: 

  • Sex-specific differences in the pathophysiology of coronary artery disease and in the manifestation of ischemic heart disease in women

  • ​The relationship between maternal mortality and cardiovascular outcomes 

  • The pathophysiology and diagnostic strategy for women with coronary microvascular disease 

  • Causes and impact of ethnic disparities on maternal mobility and mortality in women

  • ​Novel imaging and invasive techniques are used for evaluating heart disease in women, including the role of cardiac imaging in risk assessment of the transplant patient

Program Co-chairs


Renée Bullock-Palmer, MD, FASNC
Deborah Heart and Lung Center

Rupa Sanghani, MD, FASNC
Rush Medical Group

Sponsorship Opportunities

View the prospectus and contact Megan LaVine for more information.
*Credits subject to change.